MXPA03004030A - Process for the preparation of latent antithrombin iii. - Google Patents

Process for the preparation of latent antithrombin iii.

Info

Publication number
MXPA03004030A
MXPA03004030A MXPA03004030A MXPA03004030A MXPA03004030A MX PA03004030 A MXPA03004030 A MX PA03004030A MX PA03004030 A MXPA03004030 A MX PA03004030A MX PA03004030 A MXPA03004030 A MX PA03004030A MX PA03004030 A MXPA03004030 A MX PA03004030A
Authority
MX
Mexico
Prior art keywords
preparation
antithrombin iii
latent antithrombin
latent
iii
Prior art date
Application number
MXPA03004030A
Other languages
Spanish (es)
Inventor
Goran Karlsson
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0004086A external-priority patent/SE0004086D0/en
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of MXPA03004030A publication Critical patent/MXPA03004030A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
MXPA03004030A 2000-11-08 2001-11-08 Process for the preparation of latent antithrombin iii. MXPA03004030A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0004086A SE0004086D0 (en) 2000-11-08 2000-11-08 Preparation process
US25214800P 2000-11-20 2000-11-20
PCT/SE2001/002473 WO2002038610A1 (en) 2000-11-08 2001-11-08 Process for the preparation of latent antithrombin iii

Publications (1)

Publication Number Publication Date
MXPA03004030A true MXPA03004030A (en) 2004-02-12

Family

ID=26655296

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03004030A MXPA03004030A (en) 2000-11-08 2001-11-08 Process for the preparation of latent antithrombin iii.

Country Status (15)

Country Link
EP (1) EP1332159A1 (en)
JP (1) JP2004522707A (en)
KR (1) KR20030057545A (en)
AU (1) AU2002214468A1 (en)
BR (1) BR0115188A (en)
CA (1) CA2428055A1 (en)
CZ (1) CZ20031277A3 (en)
EE (1) EE200300218A (en)
HU (1) HUP0301766A3 (en)
IL (1) IL155539A0 (en)
MX (1) MXPA03004030A (en)
NO (1) NO20032048D0 (en)
PL (1) PL360410A1 (en)
RU (1) RU2003117016A (en)
WO (1) WO2002038610A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
SE0203770D0 (en) * 2002-12-19 2002-12-19 Biovitrum Ab Method of separation
JP4510898B2 (en) 2005-02-07 2010-07-28 ハヌマン リミテッド ライアビリティ カンパニー Plasma concentrator
US7694828B2 (en) 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
JP5479319B2 (en) 2007-04-12 2014-04-23 バイオメット・バイオロジックス・リミテッド・ライアビリティ・カンパニー Buoy suspension fractionation system
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
EP2259774B1 (en) 2008-02-27 2012-12-12 Biomet Biologics, LLC Methods and compositions for delivering interleukin-1 receptor antagonist
EP2254991B1 (en) 2008-02-29 2018-08-22 Biomet Manufacturing, LLC A system and process for separating a material
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9550028B2 (en) 2014-05-06 2017-01-24 Biomet Biologics, LLC. Single step desiccating bead-in-syringe concentrating device

Also Published As

Publication number Publication date
EP1332159A1 (en) 2003-08-06
KR20030057545A (en) 2003-07-04
JP2004522707A (en) 2004-07-29
WO2002038610A1 (en) 2002-05-16
PL360410A1 (en) 2004-09-06
HUP0301766A2 (en) 2003-08-28
NO20032048L (en) 2003-05-07
BR0115188A (en) 2004-02-03
HUP0301766A3 (en) 2005-12-28
RU2003117016A (en) 2004-12-10
AU2002214468A1 (en) 2002-05-21
EE200300218A (en) 2003-08-15
IL155539A0 (en) 2003-11-23
NO20032048D0 (en) 2003-05-07
CA2428055A1 (en) 2002-05-16
CZ20031277A3 (en) 2003-08-13

Similar Documents

Publication Publication Date Title
MXPA03004030A (en) Process for the preparation of latent antithrombin iii.
HK1052183A1 (en) Method for the preparation of tetrahydrobenzothiepines
ZA200110179B (en) Process for the preparation of pure citalopram.
HK1047086A1 (en) Method for the preparation of citalopram.
HK1052702A1 (en) Method for the preparation of 5-carboxyphthalide.
IL187126A0 (en) Process for the preparation of 4 - haloalkylnicotinonitriles
MXPA03001800A (en) Process for the preparation of substituted phenylacetonitriles.
MXPA02006102A (en) Process for the preparation of bromodifluoroacetic compounds.
ZA200108392B (en) Process for the preparation of substituted pyrimidines.
ZA200209168B (en) Process for the hydroxylation of aliphatic compounds.
MXPA03002464A (en) Process for the preparation of benzotriazoles.
HK1048112A1 (en) Process for the preparation of a 3-vinylcephem compound.
MXPA03005569A (en) New process.
AU8824201A (en) Process for the preparation of dinapsoline
IL190807A0 (en) Process for the preparation of 2-aminoethylpyridines
MXPA03002926A (en) Process for the synthesis of 2,2,6,6-tetramethyl-4-oxopiperidine.
IL150897A0 (en) Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides
MXPA02003042A (en) Process for preventing formation of scale.
MXPA03009210A (en) New process for the preparation of oxabispidines.
HK1040248A1 (en) Process for the preparation of isoindoline.
IL137364A (en) Process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol
SG95675A1 (en) Process for the preparation of 2,6-xylenol
MXPA03005933A (en) Process for the manufacture of solid formulations.
AU5462901A (en) Process for the preparation of (pyridinylidene)-phthalides
AU2000279379A1 (en) An improved process for the preparation of 10h-phenoxazine